World Journal of Gastrointestinal Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 12

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3071)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

146

HTML

1267

Figures (1-5)

379

Tables (1-4)

340

Sum=2132

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

130

Download

660

Sum=790

Dec 15, 2024 (publication date) through Mar 18, 2026

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Wu ZY, Li H, Chen JL, Su K, Weng ML, Han YW. Nomogram model based on γ-glutamyl transferase to albumin ratio predicts survival in hepatocellular carcinoma patients with transarterial chemoembolization treatment. World J Gastrointest Oncol 2024; 16(12): 4650-4662 [PMID: 39678787 DOI: 10.4251/wjgo.v16.i12.4650]
URL:	https://www.wjgnet.com/1948-5204/full/v16/i12/4650.htm

Number	Citing Articles
1	Sanju Sobnach, Karla Christina Sousa Silva, Ebtesam Abdel-Rashid Abdel-Shafy, Muhammad Emmamally, Catherine Wendy Spearman, Marc Bernon, Mark W Sonderup, Keith Venter, Inae Kim, Urda Kotze, Rajshree Segobin, Dale K Creamer, Stefano Cacciatore, Luiz Fernando Zerbini, Eduard Jonas. Transarterial chemoembolization outcomes for advanced hepatocellular carcinoma <i>vs</i> sorafenib and best supportive care in a sub-Saharan African cohort. World Journal of Gastroenterology 2025; 31(46): 112249 doi: 10.3748/wjg.v31.i46.112249 Abstract(52) \| Core Tip(40) \| Full Article(HTML)(279) \| Full Article with Cover (PDF)-3252K(63) \| Audio-2231K(11) \| Peer-Review Report-335K(16) \| Answering Reviewers-391K(15) \| Supplementary Material-502K(30) \| Full Article (PDF)-2905K(63) \| Full Article (XML)-184K(20) \| Times Cited (1) \| Total Visits (2309) \| Open
2	Muhammad Emmamally, Urda Kotze, Rufaida Khan, Marc Bernon, Sanju Sobnach, Jake Krige, C. Wendy Spearman, Mark Sonderup, Eduard Jonas. Secretory versus non-secretory hepatocellular carcinoma: associations of serum AFP, CEA and CA19-9 levels with clinical presentation, metastatic patterns, and survival. Journal of Circulating Biomarkers 2026; 15(1): 8 doi: 10.33393/jcb.2026.3637